Comparing the current results to its competitors, Steris Plc reported Revenue increase in the 4 quarter 2026 by 7.28 % year on year. The sales growth was above Steris Plc's competitors' average revenue growth of 5.33 %, achieved in the same quarter.
Steris Plc's Comment on Competition and Industry Peers
The company operates in the healthcare and life sciences segments, competing with various large and small firms. In the healthcare segment, product competitors include 3M, Baxter, Boston Scientific, Belimed, Ecolab, Fortive, Getinge, Karl Storz, Olympus, Ruhof, SteelCo, Stryker, Skytron, and Wassenburg. Service line competitors in healthcare comprise BBraun, Crothall, Olympus, and Pentax. In the life sciences segment, competitors include Belimed, Contec, Ecolab, Fedegari, Getinge, and Stilmas. Competition factors include product portfolios, global reach, technological innovation, product performance, convenience, ease of use, and cost-effectiveness.
With revenue growth of 7.28 % within Overall company, Steris Plc achieved improvement in market share, within Overall company to approximately 4.98 %. << More on STE Market Share.
*Market share is calculated based on total revenue.
AptarGroup Inc is a global provider of packaging solutions, specializing in dispensing systems and closures for a wide range of industries. Their business model revolves around designing and manufacturing innovative packaging solutions that enhance product functionality and consumer experience, catering to the needs of various market sectors.
Thermo Fisher Scientific Inc operates as a global leader in scientific research and services by delivering an extensive range of high-quality scientific instruments, reagents, consumables, and software solutions tailored to industries such as healthcare, pharmaceuticals, biotechnology, academia, and government. The company enhances its value proposition through a comprehensive suite of services, including laboratory outsourcing, scientific consulting, and data analysis, which help streamline research and development processes for its customers. By leveraging advanced technology and deep industry expertise, Thermo Fisher empowers researchers and organizations to drive innovation and accelerate scientific discovery.
Stryker Corps business model focuses on innovation in medical technologies and devices, specializing in areas such as orthopedics, surgical equipment, and neurotechnology, to enhance patient care and improve outcomes in the healthcare industry.
Sotera Health operates a business model focused on providing sterilization services, packaging solutions, and consultancy services for medical device and pharmaceutical companies. They utilize a network of global facilities to ensure safe and effective sterilization processes for these products. By offering comprehensive solutions, Sotera Health aims to help its clients meet regulatory requirements and maintain product integrity.
Milestone Scientific Inc's business model focuses on developing and commercializing innovative medical devices and instruments, particularly in the field of drug delivery. Their products strive to enhance patient comfort and improve clinical outcomes through precision and ease of use.
Sources:
Steris Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Steris Plc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
